1Committee of Experts on Rational Drug Use, National Health and Family Planning Commission of the P.R.China.2015年全国细菌耐药监测报告[J].中国执业药师,2016,0(3):3-8. 被引量：204
1Satlin MJ, Calfee DP, Chen L, et al. Emergence of carbapenemresistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies [J]. Leuk Lymphoma, 2013,54(4) :799-806.
2Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae , importance of combination therapy[J]. Clin Infect Dis,2012 ,55 (7) :943-950.
3Queenan AM, Bush K. Carbapenemases , the versatile beta- lactamases[J]. Clin Microbiol Rev ,2007,20(3) :440458.
4Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement, MI00-S24 [S J . Wayne, PA: Clinical and Laboratory Standards Institute ,2014.
5Gupta N, Limbago BM, Patel IB, et al. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention [J]. Clin Infect Dis, 2011 ,53 (1) :60-67.
6Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae oarhapenemasesj L]. Lancet Infect Dis,2013 ,13(9) :785-796.
7Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria [J]. Lancet Infect Dis ,2009,9 (4) :228-236.
8Temkin E, Adler A, Lerner A, et al. Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management [J] . Ann N Y Acad Sci,2014,1323:2242.
9Kritsotakis EI, Tsioutis C, Roumbelaki M, et al. Antibiotic use and the risk of carbapenem-resistant extended-spectmm-I beta 1- lactamase-producing Klebsiella pneumoniae infection III hospitalized patients: results of a double case-control study [J]. 1 Antimicrob Chemother ,2011 ,66( 6) : 1383-1391.
10Schwaber Ml, Klarleld-Lidji S, Navon-Venezia S, et al. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality [J]. Antimicrob Agents Chemother, 2008 ,52 ( 3 ) : 1028- 1033.
5Committee of Experts on Rational Drug Use, National Health and Family Planning Commission of the P.R.China.2015年全国细菌耐药监测报告[J].中国执业药师,2016,0(3):3-8. 被引量：204
